Your browser doesn't support javascript.
loading
Lactoferrin-dual drug nanoconjugate: Synergistic anti-tumor efficacy of docetaxel and the NF-κB inhibitor celastrol.
Abdelmoneem, Mona A; Abd Elwakil, Mahmoud M; Khattab, Sherine N; Helmy, Maged W; Bekhit, Adnan A; Abdulkader, Mohammad A; Zaky, Amira; Teleb, Mohamed; Elkhodairy, Kadria A; Albericio, Fernando; Elzoghby, Ahmed O.
Afiliación
  • Abdelmoneem MA; Cancer Nanotechnology Research Laboratory (CNRL), Faculty of Pharmacy, Alexandria University, Alexandria, Egypt; Department of Pharmaceutics, Faculty of Pharmacy, Damanhur University, Damanhur, Egypt; Division of Engineering in Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard
  • Abd Elwakil MM; Cancer Nanotechnology Research Laboratory (CNRL), Faculty of Pharmacy, Alexandria University, Alexandria, Egypt; Graduate school of Pharmaceutical Sciences, Hokkaido University, Japan.
  • Khattab SN; Cancer Nanotechnology Research Laboratory (CNRL), Faculty of Pharmacy, Alexandria University, Alexandria, Egypt; Department of Chemistry, Faculty of Science, Alexandria University, Alexandria 21321, Egypt. Electronic address: sh.n.khattab@gmail.com.
  • Helmy MW; Cancer Nanotechnology Research Laboratory (CNRL), Faculty of Pharmacy, Alexandria University, Alexandria, Egypt; Department of Pharmacology & Toxicology, Faculty of Pharmacy, Damanhur University, Damanhur, Egypt.
  • Bekhit AA; Cancer Nanotechnology Research Laboratory (CNRL), Faculty of Pharmacy, Alexandria University, Alexandria, Egypt; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt; Pharmacy Program, Allied Health Department, College of Health and Sport Sciences, Un
  • Abdulkader MA; Department of Biochemistry, Faculty of Science, Alexandria University, Alexandria 21511, Egypt.
  • Zaky A; Department of Biochemistry, Faculty of Science, Alexandria University, Alexandria 21511, Egypt.
  • Teleb M; Cancer Nanotechnology Research Laboratory (CNRL), Faculty of Pharmacy, Alexandria University, Alexandria, Egypt; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt.
  • Elkhodairy KA; Cancer Nanotechnology Research Laboratory (CNRL), Faculty of Pharmacy, Alexandria University, Alexandria, Egypt; Department of Industrial Pharmacy, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt.
  • Albericio F; School of Chemistry and Physics, University of KwaZulu-Natal, Durban 4001, South Africa; CIBER-BBN, Networking Centre on Bioengineering Biomaterials and Nanomedicine, Barcelona Science Park, Barcelona 08028, Spain; Department of Organic Chemistry, University of Barcelona, Barcelona 08028, Spain.
  • Elzoghby AO; Cancer Nanotechnology Research Laboratory (CNRL), Faculty of Pharmacy, Alexandria University, Alexandria, Egypt; Division of Engineering in Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA; Harvard-MIT Division of Health Sciences & Tec
Mater Sci Eng C Mater Biol Appl ; 118: 111422, 2021 Jan.
Article en En | MEDLINE | ID: mdl-33255023
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Nanopartículas / Antineoplásicos Límite: Animals / Humans Idioma: En Revista: Mater Sci Eng C Mater Biol Appl Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Nanopartículas / Antineoplásicos Límite: Animals / Humans Idioma: En Revista: Mater Sci Eng C Mater Biol Appl Año: 2021 Tipo del documento: Article